Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
The closing price of Psyence Biomedical Ltd (NASDAQ: PBM) was $1.53 for the day, down -3.77% from the previous closing price of $1.59. In other words, the price has decreased by -$3.77 from its previous closing price. On the day, 0.42 million shares were traded. PBM stock price reached its highest trading level at $1.6099 during the session, while it also had its lowest trading level at $1.4901.
Ratios:
Our analysis of PBM’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 8.09 and its Current Ratio is at 8.09. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PBM now has a Market Capitalization of 2864238 and an Enterprise Value of -4285747.
Stock Price History:
The Beta on a monthly basis for PBM is 0.27, which has changed by -0.9025735 over the last 52 weeks, in comparison to a change of 0.13042927 over the same period for the S&P500. Over the past 52 weeks, PBM has reached a high of $62.72, while it has fallen to a 52-week low of $1.41. The 50-Day Moving Average of the stock is -43.91%, while the 200-Day Moving Average is calculated to be -64.04%.
Shares Statistics:
PBM traded an average of 1.17M shares per day over the past three months and 1745140 shares per day over the past ten days. Insiders hold about 0.00% of the company’s shares, while institutions hold 9.37% stake in the company. Shares short for PBM as of 1764288000 were 102238 with a Short Ratio of 0.09, compared to 1761868800 on 78860. Therefore, it implies a Short% of Shares Outstanding of 102238 and a Short% of Float of 5.46.
